The Utility of Food-Specific IgE Measured With the IMMULITE 2000 Assay to Predict Symptomatic Food Allergy (IMMULITE 2000)
Sponsor: National Jewish Health
Listed as NCT01950533, this observational or N/A phase trial focuses on Egg Allergy and Milk Allergy and remains completed. Sponsored by National Jewish Health, it has been updated 9 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
Status: Unknown Status → Completed
-
Oct 2019 — Nov 2020 [monthly]
Unknown Status
Status: Active Not Recruiting → Unknown Status
▶ Show 4 earlier versions
-
Jun 2018 — Oct 2019 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Apr 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Apr 2017 [monthly]
Recruiting NA
First recorded
Sep 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Jewish Health
For direct contact, visit the study record on ClinicalTrials.gov .